Since the beginning of vaccination programs against COVID-19 in different countries, several populations such as patients with specific immunological conditions have been …
Objective To update guidance regarding the management of psoriatic disease during the COVID-19 pandemic. Study Design The task force (TF) includes 18 physician voting …
GP Mishra, J Mulani - The Lancet Respiratory Medicine, 2021 - thelancet.com
Michael A Matthay and B Taylor Thompson1 have very nicely summarised the evidence- based role of dexamethasone in hospitalised patients with COVID-19. Their pertinent …
X Xu, W Jiang, L Chen, Z Xu, Q Zhang… - Clinical and …, 2021 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) was identified in December 2019 and has …
R Kaur, DL Vines, S Mirza, A Elshafei, JA Jackson… - Critical Care, 2021 - Springer
Background Awake prone positioning (APP) is widely used in the management of patients with coronavirus disease (COVID-19). The primary objective of this study was to compare …
D Annane - Journal of Intensive Medicine, 2021 - mednexus.org
Coronavirus disease 19 (COVID-19) is placing a major burden on healthcare, economy and social systems worldwide owing to its fast spread and unacceptably high death toll. The …
M Thakur, AK Datusalia, A Kumar - European Journal of Pharmacology, 2022 - Elsevier
Background Emerging reports have shown the benefits of steroids in hospitalized COVID-19 patients as life-saving drugs. However, the use of steroids in COVID-19 patients is confusing …
Background The clinical course of COVID-19 may vary significantly. The presence of comorbidities prolongs the recovery time. The recovery in patients with mild-to-moderate …
K Pushparaj, HK Bhotla, VA Arumugam… - Science of The Total …, 2022 - Elsevier
Post COVID-19, mucormycosis occurred after the SARS-CoV-2 has rampaged the human population and is a scorching problem among the pandemic globally, particularly among …